Abstract
Different experimental autoimmune encephalomyelitis models (EAE) have been developed. However, due to the different experimental conditions applied, observations simultaneously considering different pathological targets are still scarce. Using EAE induced in Dark Agouti rats with syngenic whole spinal cord homogenate suspended in incomplete Freund’s adjuvant, we here analyze neurosteroidogenic machinery, cytokine levels, microglial cells, infiltration of inflammatory cells, myelin proteins and Na+, K+-ATPase pump activity in the spinal cord. Data obtained in the acute phase of the disease confirmed that neurological signs were accompanied by the presence of perivascular infiltrating T cells (CD3+ cells) and activated monocytic/microglial cells (ED1+ and MHC-II+) in the spinal cord. In particular, the number of MHC-II+ cells was significantly increased in association with increased expression of pro- (i.e., TNF-α, IL-1β) and anti-inflammatory (i.e., TGF-β) cytokines as well as with decreased expression of proteolipid protein and myelin basic protein. During the chronic phase of the disease, the number of MHC-II+ cells was still increased, although less than in the acute phase. Changes in the number of MHC-II+ cells were associated with decreased Na+,K+-ATPase enzymatic activity. A general decrease in the levels of neuroactive steroids, with the exception of an increase in tetrahydroprogesterone and 17β-estradiol, was detected in the acute phase. These changes were maintained or reverted in the chronic phase of EAE. In conclusion, we report that modifications in the neuroimmune response in the acute and chronic phases of EAE are associated with specific changes in myelin proteins, Na+,K+-ATPase pump and in the levels of neuroactive steroids.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arevalo MA, Santos-Galindo M, Bellini MJ, Azcoitia I, Garcia-Segura LM (2010) Actions of estrogens on glial cells: Implications for neuroprotection. Biochim Biophys Acta 1800:1106–1112
Benveniste EN (1997) Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 755:16173
Bianchi R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, Lauria G, Borgna M, Lombardi R, Cimen B, Comelekoglu U, Kanik A, Tataroglu C, Cerami A, Ghezzi P (2004) Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A 101:823–828
Brown CM, Mulcahey TA, Filipek NC, Wise PM (2010) Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta. Endocrinology 151:4916–4925
Caruso D, Scurati S, Maschi O, De Angelis L, Roglio I, Giatti S, Garcia-Segura LM, Melcangi RC (2008) Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem Int 52:560–568
Caruso D, D’Intino G, Giatti S, Maschi O, Pesaresi M, Calabrese D, Garcia-Segura LM, Calza L, Melcangi RC (2010a) Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis. J Neurochem 114:921–932
Caruso D, Pesaresi M, Maschi O, Giatti S, Garcia-Segura LM, Melcangi RC (2010b) Effects of short- and long-term gonadectomy on neuroactive steroid levels in the central and peripheral nervous system of male and female rats. J Neuroendocrinol 22:1137–1147
Cavaletti G, Perseghin P, Buscemi F, Dassi M, Oggioni N, Sala F, Lolli F, Liuzzi GM, Riccio P, Frattola L, Tredici G (2001a) Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis. Int J Tissue React 23:21–31
Cavaletti G, Perseghin P, Dassi M, Oggioni N, Sala F, Lolli F, Riccio P, Tredici G, Frattola L (2001b) Extracorporeal photochemotherapy reduces the incidence of relapses in experimental allergic encephalomyelitis in DA rats. J Neurol 248:535–536
Cavaletti G, Perseghin P, Dassi M, Oggioni N, Sala F, Braga M, Lolli F, Riccio P, Carlone G, Zoia C, Tagliabue E, Stanzani L, Galbiati S, Rigamonti L, Marmiroli P, Ferrarese C, Frattola L, Tredici G (2004) Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells. J Biol Regul Homeost Agents 18:9–17
Cerciat M, Unkila M, Garcia-Segura LM, Arevalo MA (2010) Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 58:93–102
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
Darlington C (2002) Multiple sclerosis and gender. Curr Opin Investig Drugs 3:911–914
El-Etr M, Vukusic S, Gignoux L, Durand-Dubief F, Achiti I, Baulieu EE, Confavreux C (2005) Steroid hormones in multiple sclerosis. J Neurol Sci 233:49–54
Foster SC, Daniels C, Bourdette DN, Bebo BF Jr (2003) Dysregulation of the hypothalamic-pituitary-gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroimmunol 140:78–87
Gago N, Akwa Y, Sananes N, Guennoun R, Baulieu EE, El-Etr M, Schumacher M (2001) Progesterone and the oligodendroglial lineage: stage-dependent biosynthesis and metabolism. Glia 36:295–308
Garcia-Ovejero D, Azcoitia I, Doncarlos LL, Melcangi RC, Garcia-Segura LM (2005) Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res Brain Res Rev 48:273–286
Garcia-Segura LM, Melcangi RC (2006) Steroids and glial cell function. Glia 54:485–498
Giatti S, D’Intino G, Maschi O, Pesaresi M, Garcia-Segura LM, Calza L, Caruso D, Melcangi RC (2010) Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels. Neurochem Int 56:118–127
Hartung HP, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ, Toyka KV (1992) Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 40:197–210
Hatton WJ, von Bartheld CS (1999) Analysis of cell death in the trochlear nucleus of the chick embryo: calibration of the optical disector counting method reveals systematic bias. J Comp Neurol 409:169–186
Holmqvist P, Wallberg M, Hammar M, Landtblom AM, Brynhildsen J (2006) Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 54:149–153
Johns LD, Sriram S (1993) Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease. J Neuroimmunol 47:1–7
Kassiotis G, Pasparakis M, Kollias G, Probert L (1999) TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis. Eur J Immunol 29:774–780
Kipp M, Beyer C (2009) Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Front Neuroendocrinol 30:188–200
Labombarda F, Gonzalez SL, Lima A, Roig P, Guennoun R, Schumacher M, de Nicola AF (2009) Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia 57:884–897
Lenz DC, Wolf NA, Swanborg RH (1999) Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis. J Immunol 163:1763–1768
Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, Lauria G, Magnaghi V, Roglio I, Melcangi RC (2007) Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 144:1293–1304
Link H (1998) The cytokine storm in multiple sclerosis. Mult Scler 4:12–15
Lorentzen JC, Issazadeh S, Storch M, Mustafa MI, Lassman H, Linington C, Klareskog L, Olsson T (1995) Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund’s adjuvant. J Neuroimmunol 63:193–205
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Maccio DR, Calfa G, Volosin M, Roth GA (2004) Serum testosterone and corticosterone levels in acute experimental autoimmune encephalomyelitis (EAE) in male Wistar rats. Neuro Endocrinol Lett 25:196–200
McCombe PA, Harness J, Pender MP (1999) Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neuroimmunol 97:60–69
Melcangi RC, Panzica GC (2006) Neuroactive steroids: old players in a new game. Neuroscience 138:733–739
Melcangi RC, Garcia-Segura LM, Mensah-Nyagan AG (2008) Neuroactive steroids: state of the art and new perspectives. Cell Mol Life Sci 65:777–797
Minagar A, Alexander JS (2003) Blood-brain barrier disruption in multiple sclerosis. Mult Scler 9:540–549
Owens T, Tran E, Hassan-Zahraee M, Krakowski M (1998) Immune cell entry to the CNS–a focus for immunoregulation of EAE. Res Immunol 149:781–789, discussion 844–786, 855–760
Papenfuss TL, Powell ND, McClain MA, Bedarf A, Singh A, Gienapp IE, Shawler T, Whitacre CC (2011) Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. J Immunol 186:3346–3355
Pesaresi M, Maschi O, Giatti S, Garcia-Segura LM, Caruso D, Melcangi RC (2010) Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm Behav 57:46–55
Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE (1991) Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol 146:3012–3017
Rigolio R, Biffi A, Oggioni N, Cavaletti G (2008) Actively induced EAE in Lewis rats: characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease. J Neuroimmunol 199:67–74
Roglio I, Bianchi R, Gotti S, Scurati S, Giatti S, Pesaresi M, Caruso D, Panzica GC, Melcangi RC (2008) Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury. Neuroscience 155:673–685
Safarinejad MR (2008) Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis. J Neuroendocrinol 20:1368–1375
Schumacher M, Sitruk-Ware R, De Nicola AF (2008) Progesterone and progestins: neuroprotection and myelin repair. Curr Opin Pharmacol 8:740–746
Schwendimann RN, Alekseeva N (2007) Gender issues in multiple sclerosis. Int Rev Neurobiol 79:377–392
Shrikant P, Benveniste EN (1996) The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J Immunol 157:1819–1822
Tapia-Gonzalez S, Carrero P, Pernia O, Garcia-Segura LM, Diz-Chaves Y (2008) Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs. J Endocrinol 198:219–230
Tapia-Gonzalez S, Garcia-Segura LM, Tena-Sempere M, Frago LM, Castellano JM, Fuente-Martin E, Garcia-Caceres C, Argente J, Chowen JA (2011) Activation of microglia in specific hypothalamic nuclei and the cerebellum of adult rats exposed to neonatal overnutrition. J Neuroendocrinol 23:365–370
Tomassini V, Pozzilli C (2006) Sex hormones: a role in the control of multiple sclerosis? Expert Opin Pharmacother 7:857–868
Tomassini V, Onesti E, Mainero C, Giugni E, Paolillo A, Salvetti M, Nicoletti F, Pozzilli C (2005) Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry 76:272–275
Vukusic S, Confavreux C (2006) Pregnancy and multiple sclerosis: the children of PRIMS. Clin Neurol Neurosurg 108:266–270
Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P, Confavreux C, The Pregnancy In Multiple Sclerosis G (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127:1353–1360
Acknowledgments
The financial support of Fondazione Italiana Sclerosi Multipla (2010/23) to R. C. Melcangi is gratefully acknowledged. We wish also to thanks Dr. Donatella Crippa and Dr. Stefano Valzelli (Bayer Schering Pharma) for the critical reading of the manuscript and Bayer Schering Pharma for the financial support.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giatti, S., Boraso, M., Abbiati, F. et al. Multimodal Analysis in Acute and Chronic Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol 8, 238–250 (2013). https://doi.org/10.1007/s11481-012-9385-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-012-9385-9